glp-1 breast cancer recurrence GLP-1 receptor agonists in the context of cancer: the road ahead | American Journal of Physiology-Cell Physiology

Frontiers

23.91

★★★★☆4.8 (126)

These results provide new hope for breast cancer patients. While it's important not to draw premature conclusions from observational data, the findings align with a substantial body of evidence indicating improved health

25.10

★★★★★4.9 (98)

Could GLP-1 medications play a role in reducing breast cancer recurrence risk? In a story for Oprah Daily, Melinda Irwin, PhD, MPH, explains that weight management can improve inflammation, metabolism, immune function,

29.29

★★★★★5.0 (157)

GLP-1 Receptor Agonists Show a Striking Signal in Breast Cancer Outcomes, but Big Questions Remain

29.47

★★★★★4.7 (84)

The Impact and Safety of GLP‐1 Agents and Breast Cancer - Parsons - 2025 - Cancer Medicine

29.41

★★★★★4.9 (203)

Researchers from Penn Medicine found that women taking GLP-1 drugs are less likely to be diagnosed with breast cancer. @drcelinegounder breaks down the study's findings and whether the drugs caused the difference

24.27

★★★★★5.0 (176)

There's a surprising new benefit from taking GLP-1 weight loss drugs—using the medication is associated with lower breast cancer incidents, according to a published study. Latest Medical Watch Daily Digest: ( https://wgntv.com/news/medical-watch/glp-1

20.99

★★★★★4.8 (132)